Assessment of quality of life * in health services research conceptual, methodological and structural prerequisites **;Die erfassung von lebensqualität * in der versorgungsforschung konzeptuelle, methodische und strukturelle voraussetzungen **

Gesundheitswesen

Volumn 71, Issue 12, 2009, Pages 864-872

  Koller, M ^a   Neugebauer, E A M ^b   Augustin, M ^c   Bussing A ^b   Farin, E ^d   Klinkhammer Schalke, M ^e   Lorenz, W ^e   Munch K ^a   Petersen Ewert, C ^c   Steinbüchel, N Von ^f   Wieseler, B ^g  

^a Klinik und Poliklinik für Neurochirurgie Universitäts Klinikum Regensburg   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g Institut für Qualitätssicherung und Wirtschaftlichkeit im Gesundheitswesen Köln   (Germany)

Author keywords

Health services research; Quality criteria and selection of assessment instruments; Quality criteria for studies; Quality of life

Indexed keywords

ARTICLE; GERMANY; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PSYCHOMETRY; QUALITY OF LIFE; STANDARD;

GERMANY; HEALTH SERVICES RESEARCH; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PSYCHOMETRICS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE;

EID: 74549171528     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0029-1239516     Document Type: Review

References (74)

1. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. Journal of Clinical Oncology 1996 14 671-679
2. FDA & U. S. Department of Health and Human Services. Guidance for Industry. Patient-reported outcome measures: Use in medical product development to support labeling claims 2006 www.fda.gov/cder/guidance/5460dft.pdf
3. EMEA. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products 2005 www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf
4. Chassany O, Sagnier P, Marquis P, et al The ERIQA group. Patient-reported outcomes: the example of health-related quality of life a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal 2002 36 209-238
5. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen 2008. Allgemein Methoden Version 3.0 vom 27.05.2008 www.iqwig.de/download/iqwig-methoden-version-3-0.pdf [Zugriff am 06.06.2008]
6. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 2009 45 347-353
7. Troidl H, Menge KH, Lorenz W, et al. Quality of life and stomach replacement. In Herfarth M, Schlag PM, Hrsg. Gastric Cancer. Berlin, Springer 1979 312-317
8. Bauhofer A, Plaul U, Torossian A, et al. Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial. Surgery 2007 141 501-510
9. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 2008 35 896-908
10. Wright JR, Ung YC, Julian JA, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. Journal of Clinical Oncology 2007 25 1027-1032
11. Arbeitskreis Versorgungsforschung beim Wissenschaftlichen Beirat. 2004 Definition und Abrenzung der Versorgungsforschung www.versorgungsforschung.nrw. de/content/e54/e104/e259/object260/def-versorgungsforsch-2004-baek.pdf
12. Patrick DL, Erickson P. Health status and health policy: Quality of life in health care evaluation and resource allocation New York: Oxford University Press 1993
13. Siegrist J. Grundannahmen und gegenwärtige Entwicklungsperspektiven einer gesundheitsbezogenen Lebensqualitätsforschung. In Schölmerich P, Thews G, Hrsg. Lebensqualität als Bewertungskriterium in der Medizin Stuttgart: Fischer 1990 59-66
14. Bullinger M. Gesundheitsbezogene Lebensqualität und subjektive Gesundheit. Psychotherapie Psychosomatik Medizinische Psychologie 1997 47 76-91
15. Howard-Jones N. The World Health Organization in historical perspective. Perspectives in Biology and Medicine 1981 24 467-482
16. Koller M, Lorenz W. Quality of life: a deconstruction for clinicians. Journal of the Royal Society Medicine 2002 95 481-488
17. Najman JM, Levine S. Evaluating the Impact of Medical Care and Technology on Quality of Life: A Review and Critique. Social Science & Medicine 1981 15 107-115
18. Neugebauer E, Troidl H, Wood-Dauphinée S, et al. Meran consensus conference on quality-of-life assessment in surgery. Part I. Theoretical Surgery 1991 6 123-165
19. Bullinger, M. Quality of life: definition, conceptualization and implications a methodologist's view. Theoretical Surgery 1991 6 143-148
20. Pennebaker JW. The psychology of physical symptoms New York: Springer 1982
21. Koller M, Kussmann J, Lorenz W, et al. Symptom reporting in cancer patients: The role of negative affect and experienced social stigma. Cancer 1996 77 983-995
22. Büssing A, Ostermann T, Matthiessen PF. Adaptives Coping und Spiritualität als Ressource bei Krebspatienten. PRäVENTION Zeitschrift für Gesundheitsförderung 2008 31 51-53
23. Büssing A, Ostermann T, Koenig H. Relevance of religion and spirituality in German patients with chronic diseases. International Journal of Psychiatry in Medicine 2007 37 39-57
24. Eriksson M, Lindström B. Antonovsky's sense of coherence scale and the relation with health: a systematic review. Journal of Epidemiology & Community Health 2006 60 381
25. Tagay S, Erim Y, Brähler E, et al. Religiosity and sense of coherence Protective factors of mental health and well-being? Zeitschrift für Medizinische Psychologie 2006 15 165-171
26. vSteinbüchel N, Richter S, Morawetz C. Assessment of subjective health and health-related quality of life in persons with acquired or degenerative brain injury. Current Opinion in Neurology 2005 18 681-691
27. Smith SC, Lamping DL, Banerjee S. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technology Assessment 2005 9 1-93
28. vSteinbüchel N, Petersen N, Bullinger M. The QOLIBRI Group Assessment of health-related quality of life in persons after traumatic brain injury development of the QOLIBRI, a specific measure. Acta Neurochirurgica 2005 43-49
29. Berger E, Leven F, Pirente N, et al. Quality of life after traumatic brain injury: A systematic review of the literature. Restorative Neurology and Neuroscience 1999 14 93-102
30. Troidl H, Wechsler AS, McKneally MF. How to choose a relevant endpoint. In Troidl H, McKneally MF, Mulder DS, Wechsler AS, McPeek B, Spitzer WO, Hrsg. Surgical research. Basic principles and clinical practice (3 ed.) New York: Springer 1998 303-319
31. Lorenz W, Troidl H, Solomkin JS, et al. Second step: Testing Outcome measurements. World Journal of Surgery 1999 23 768-780
32. Klinkhammer-Schalke M, Koller M, Wyatt JC, et al. Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling). Langenbeck's Archives of Surgery 2008 393 1-12
33. Janse AJ, Gemke RJBJ, Uiterwaal CSPM, et al. Quality of life: patients and doctors dont always agree: a meta-analysis. Journal of Clinical Epidemiology 2004 57 653-661
34. Klinkhammer-Schalke M, Koller M, Ehret C, et al. Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. British Journal of Cancer 2008 99 415-422
35. Schwartz CE, Bode R, Repucci N, et al. The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research 2006 15 1533-1550
36. van Campen C, Sixma H, Friele RD, et al. Quality of care and patient satisfaction: A review of measuring instruments. Medical Care Research and Review 1995 52 109-133
37. Hardy GE, West MA, Hill F. Components and predictors of patient satisfaction. British Journal of Health Psychology 1996 1 65-85
38. Bennett KJ, Torrance GW. Measuring Health State Preferences and Utilities: Rating Scale, Time Trade-Off, and Standard Gamble Techniques. In Spilker B, Hrsg. Quality of Life and Pharmacoeconomics in Clinical Trials Philadelphia: Lippincott Williams & Wilkins 1996 253-265
39. Stevens KJ, Brazier JE, McKenna SP, et al. The development of a preference-based measure of health in children with atopic dermatitis. British Journal of Dermatology 2005 153 373-377
40. Froberg DG, Kane RL. Methodology for measuring health-state preferences I: Measurement strategies. Journal of Clinical Epidemiology 1989 42 345-354
41. Gesundheitsforschungsrat des BMBF. Diskussionsforum zur Nutzenbewertung im Gesundheitswesen. Begriffsdefinition und Einführung Dokumentation des 1. gemeinsamen Workshops von GFR und IQWIG am 4. September 2007 in Berlin. www.gesundheitsforschung-bmbf.de/de/1191.php
42. Bullinger M, Anderson R, Cella D, et al. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Quality of Life Research 1993 2 451-459
43. Koller M, Aaronson NK, Blazeby J, et al. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. European Journal of Cancer 2007 43 1810-1820
44. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life banks Plans for the Patient-Reported Outcome Measurement Information System (PROMIS). Medical Care 2007 45 22-31
45. Koller M. Outcome und Lebensqualität. In Jauch KW, Mutschler W, Wichmann MW, Hrsg. Chirurgie Basisweiterbildung Heidelberg: Springer Medizin Verlag 2007 583-589
46. Albers S, Klapper D, Konradt U, et al. Methodik der empirischen Forschung Wiesbaden: Gabler 2007
47. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of care. Journal of Clinical Epidemiology 2003 56 395-407
48. Schumacher J, Klaiberg A, Brähler E. Diagnostische Verfahren zu Lebensqualität und Wohlbefinden Göttingen: Hogrefe 2003
49. Bowling A. Measuring disease. A review of disease-specific quality of life measurement scales. (2 ed.) Buckingham: Open University Press 2001
50. rd ed.) Oxford: Oxford Univ. Press 2006
51. Bullinger M, Ravens-Sieberer U. Diagnostik der Lebensqualität In R. D. Stieglitz, U. Baumann & M. Freyberger, Eds. Psychodiagnostik in Klinischer Psychologie, Psychiatrie, Psychotherapie Berlin: Thieme Verlag 2001 246-257
52. Petersen C, Schmidt S, Power M, DISABKIDS Group. Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: A European perspective. Quality of Life Research 2005 14 1065-1077
53. Kind P, Dolan P, Gudex C, et al. Variations in population healt status: results from a United Kingdom national questionnaire survey. British Medical Journal 1998 316 736-741
54. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993 85 365-376
55. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology 1993 11 570-579
56. Ravens-Sieberer U, Gosch A, Rajmil L, et al. The KIDSCREEN-52 Quality of life measure for children and adolescents: Development and first results from a European survey. Expert Review of Pharmacoeconomics & Outcomes Research 2005 5 353-364
57. Ravens-Sieberer U, Bullinger M. Assessing health related quality of life in chronically ill children with the German KINDL: First psychometric and content analytical results. Quality of Life Research 1998 7 399-407
58. Kohlmann T, Bullinger M, Raspe H. Die deutsche Form des Nottingham Health Profiles Skalenstruktur, Reliabilität und Validität. Zeitschrift für Sozial-und Präventivmedizin 1997 42 175-185
59. Siegrist J, Broer M, Junge A. PLC Profil der Lebensqualität chronisch Kranker Göttingen: Beltz Test 1996
60. Pirente N, Bouillon B, Schäfer B, et al. Systematic development of a scale for determination of health-related quality of life in multiple trauma patients. The Polytrauma Outcome (POLO) Chart. Unfallchirurgie 2002 105 413-422
61. McGee HM, OBoyle CA, Hickey A, et al. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychological Medicine 1991 21 749-759
62. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Medical Care 1992 30 473
63. Bergner M, Bobbitt SA, Carter WB, et al. The Sickness Impact Profile: Development and final revision of a health status measure. Medical Care 1981 19 780-805
64. The WHOQOL Group. The Development of the WHO Quality of Life Assessment Instrument (The WHOQOL) Paris: IPSEN Foundation Press 1993
65. Osoba D, Aaronson NK, Till JE. A practical guide for selecting quality-of-life measures in clinical trials and practice. In D. Osoba, Hrsg. Effect of cancer on quality of life Boca Radon: CRC 1991 90-104
66. Götz S, Lunz B, Koller M, et al. Evaluation der Lebensqualität bei adjuvanter endokriner Therapie des Mammakarzinoms: Pilotstudie zur Auswahl eines geeigneten Messinstruments Senologie Zeitschrift für Mammadiagnostik und therapie 2007 DOI: 10.1055/s-2007-982941
67. Lehoux P, Poland B, Daudelin G. Focus group research and the patient's view Social Science & Medicine 2006 63 2091-2104
68. Willis GB. Cognitive interviewing. A tool for improving questionnaire designs Thousand Oaks, Californien: Sage Publ 2005
69. Ciechanowski P, Katon WJ. The interpersonal experience of health care through the eyes of patients with diabetes. Social Science & Medicine 2006 63 3067-3079
70. Efficace F, Osoba D, Gotay C, et al. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology 2007 18 775-781
71. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. British Medical Journal 2008 336 601-605
72. Glasziou PP, Chalmers I, Rawlins M, et al. When are randomised trials unnecessary? Picking signal from noise. British Medical Journal 2007 334 349-351
73. Sugano DS, McElwee NE. An epidemiologic perspective. In Spilker B, Ed. Quality of Life in Clinical Trials Philadelphia: Lippincott-Raven Publishers 1996 555-561
74. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001 357 1191-1194 (Pubitemid 32378696)